| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |